Timely clinical updates and thought leadership on new drug and indication approvals, discontinuation and withdrawals, new dosages or formulations of existing products and generics introduced to the market. For questions regarding new updates, please email clinical@myMatrixx.com.
News and Updates
One Lot of Tramadol Recalled
May 15, 2024
On May 1, 2024, Rubicon Research Pvt. Ltd. recalled one lot of tramadol hydrochloride 50 mg tablets after it was reported that a different medication, baclofen 10 mg tablets, could be mixed in with one lot of the tramadol hydrochloride 50 mg tablets.
Learn more
FDA Approves New Naloxone Products
May 02, 2024
Get the latest updates about newly, FDA-approved Rezenopy (naloxone hydrochloride) and naloxone nasal spray, 4mg/0.1mL, a generic to the OTC version of Narcan.
Learn more
Q1 2024 New Drug Report (January - March)
April 17, 2024
Read our new Q1 2024 (January through March) pipeline report that features new drug approvals, new generics, withdrawals and discontinuations of certain products, as well as near-term pipeline products and patent expirations.
Learn more
ODG Formulary Changes Planned for March 29
March 26, 2024
Effective March 29, ODG is updating Appendix A (its drug formulary). The planned changes will affect opioids, non-steroidal anti-inflammatory drugs (NSAIDs) and sedative hypnotics.
Learn more